March 2022: The Food and Drug Administration has approved rituximab (Rituxan, Genentech, Inc.) in conjunction with chemotherapy for CD20-positive diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma..
British scientists begin genetic testing of childhood tumors. British scientists hope that genetic testing will give younger patients newer and more personalized treatments that will increase their survival. The new test analyze..